STOKE THERAPEUTICS INC (STOK:NASDAQ)

$26.13 0.67 (2.6316%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 82

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed STOKE THERAPEUTICS INC (STOK:NASDAQ) News Sources

Stoke Therapeutics shares rise as JPMorgan starts coverage with Overweight rating

21-08-2026

advfn.com

What Is Stoke Therapeutics (STOK) Signaling With A 2 Million Share Shelf Filing?

07-08-2026

yahoo.com

Stoke Therapeutics (STOK) Q2 2026 Earnings Call Transcript

11-08-2026

fool.com

Stoke Therapeutics’ Dravet Trial Tops Enrollment Target With Zero Dropouts

18-08-2026

marketbeat.com

Stoke Therapeutics and Biogen Present Long-Term Clinical Data that Support the Disease-Modifying Potential of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 16th European Epilepsy Congress (EEC)

03-09-2026

yahoo.com

Stoke Therapeutics Announces Presentations of STK-002, an Investigational Medicine for the Treatment of Autosomal Dominant Optic Atrophy (ADOA), at the American Academy of Ophthalmology (AAO) 2026 Annual Meeting

06-10-2026

yahoo.com

FDA Alignment on Zorevunersen Endpoints Could Be A Game Changer For Stoke Therapeutics (STOK)

09-10-2026

yahoo.com

Stoke Therapeutics Presents Data Supporting the Disease-Modifying Potential of STK-002 in Autosomal Dominant Optic Atrophy (ADOA) at the American Academy of Ophthalmology (AAO) 2026 Annual Meeting

12-10-2026

yahoo.com

Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

16-10-2026

yahoo.com

Stoke Therapeutics to Host Webcast and Conference Call to Discuss Third Quarter 2026 Business and Financial Updates

22-10-2026

yahoo.com

STOKE THERAPEUTICS INC (STOK:NASDAQ) Sentiment Trend

0 25 50 75 100 92 86 76 85 76 66 88 81 85 89 21-08-2026 07-08-2026 11-08-2026 18-08-2026 03-09-2026 06-10-2026 09-10-2026 12-10-2026 16-10-2026 22-10-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

STOKE THERAPEUTICS INC (STOK:NASDAQ) FAQs

toggle

What is the current price of STOKE THERAPEUTICS INC (STOK:NASDAQ)?

The current price of STOKE THERAPEUTICS INC (STOK:NASDAQ) is $26.13.


toggle

STOKE THERAPEUTICS INC (STOK:NASDAQ) absolute price change since previous trading day?

The absolute price change of STOKE THERAPEUTICS INC (STOK:NASDAQ) since the previous trading day is $0.67.


toggle

STOKE THERAPEUTICS INC (STOK:NASDAQ) percentage price change since previous trading day?

The percentage price change of STOKE THERAPEUTICS INC (STOK:NASDAQ) since the previous trading day is 2.6316%.


toggle

What is the most recent average sentiment score for STOKE THERAPEUTICS INC (STOK:NASDAQ)?

The most recent average sentiment score for STOKE THERAPEUTICS INC (STOK:NASDAQ) is 82 out of 100.


toggle

What is the most recent average sentiment for STOKE THERAPEUTICS INC (STOK:NASDAQ)?

The most recent sentiment for STOKE THERAPEUTICS INC (STOK:NASDAQ) is .


SEC-8K** Filing Available For STOKE THERAPEUTICS INC (STOK:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.